Cardinal Health Inc  

(Public, NYSE:CAH)   Watch this stock  
Find more results for CAH
-0.12 (-0.13%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 90.90 - 91.78
52 week 63.06 - 91.89
Open 91.41
Vol / Avg. 1.32M/1.60M
Mkt cap 30.17B
P/E 28.19
Div/yield 0.34/1.50
EPS 3.24
Shares 330.13M
Beta 0.52
Inst. own 88%
Apr 30, 2015
Q3 2015 Cardinal Health Inc Earnings Release - 9:30AM EDT - Add to calendar
Apr 30, 2015
Q3 2015 Cardinal Health Inc Earnings Call - 8:30AM EDT - Add to calendar
Mar 10, 2015
Cardinal Health Inc at Barclays Healthcare Conference (Breakout Session) - Webcast
Mar 10, 2015
Cardinal Health Inc at Barclays Healthcare Conference - Webcast
Mar 3, 2015
Cardinal Health Inc at Cowen Health Care Conference (Breakout Session) - Webcast
Mar 3, 2015
Cardinal Health Inc at Cowen Health Care Conference - Webcast
Mar 2, 2015
Cardinal Health Inc To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash M&A Call
Feb 24, 2015
Cardinal Health Inc at RBC Healthcare Conference - Webcast
Feb 12, 2015
Cardinal Health Inc at Leerink Global Healthcare Conference - Webcast
Jan 29, 2015
Q2 2015 Cardinal Health Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 1.13% 1.28%
Operating margin 1.90% 2.07%
EBITD margin - 2.81%
Return on average assets 4.38% 4.49%
Return on average equity 18.76% 18.79%
Employees 34,000 -
CDP Score - 75 E


7000 Cardinal Pl
DUBLIN, OH 43017-1091
United States - Map
+1-614-7573033 (Phone)
+1-614-7576000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products and services that help pharmacies, hospitals and other healthcare providers focus on patient care. The Company reports its financial results in two segments: Pharmaceutical and Medical. In the United States, the Pharmaceutical segment, distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals and other healthcare providers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers in the United States, Canada and China and to patients in the home in the United States.

Officers and directors

George S. Barrett Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Michael C. Kaufmann Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Donald M. Casey Jr. Chief Executive Officer - Medical Segment
Age: 54
Bio & Compensation  - Reuters
Jon Giacomin Chief Executive Officer - Pharmaceutical segment
Bio & Compensation  - Reuters
Carole S. Watkins Chief Human Resource Officer
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stephen T. Falk Executive Vice President, General Counsel, Corporate Secretary
Age: 49
Bio & Compensation  - Reuters
Mark R. Blake Executive Vice President - Strategy and Corporate Development
Age: 43
Bio & Compensation  - Reuters
Craig S. Morford Chief Legal and Compliance Officer
Age: 55
Bio & Compensation  - Reuters
Patricia A. Hemingway Hall Director
Age: 55
Bio & Compensation  - Reuters
David John Anderson Independent Director
Age: 71
Bio & Compensation  - Reuters